At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,958 enrolled
Drug / intervention
PrEP Optimization Interventionsother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
PrEPARE: PrEP in Pregnancy, Accelerating Reach and Efficiency
In Brief
A clinical study evaluating PrEP Optimization Interventions for Pre-Exposure Prophylaxis and 2 related conditions. Completed, enrolled 1,958 participants across 8 sites.
Detailed Summary
This study tests strategies for improving PrEP implementation in maternal and child health clinics using a difference-in-difference approach.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPre-Exposure Prophylaxis, HIV Infections, Pregnancy Related
CountriesKenya
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedJan 2021
Enrollment StartMay 2021
Primary CompletionNov 2021
Study CompletionJan 2022
TodayJul 2026
First PostedJan 19, 2021
Enrollment StartMay 1, 2021
Primary CompletionNov 30, 2021
Study CompletionJan 31, 2022
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 5.5 years ago
Interventions
PrEP Optimization Interventionsother
A bundle of strategies (video-based PrEP counselling, HIV Self-Testing \[HIVST\] for women undergoing repeat HIV testing, and optimized PrEP delivery and prescription processes) will be implemented in the intervention group.